Free Trial
NYSEARCA:BMED

iShares Health Innovation Active ETF (BMED) Price, Holdings, & News

$28.49 +0.03 (+0.11%)
As of 10:18 AM Eastern

About iShares Health Innovation Active ETF (NYSEARCA:BMED)

Advanced

Key Stats

Today's Range
$28.49
$28.49
50-Day Range
$27.26
$29.51
52-Week Range
$24.20
$32.19
Volume
120 shs
Average Volume
4,134 shs
Market Capitalization
$10.26 million
Assets Under Management
$10.24 million
Dividend Yield
N/A
Net Expense Ratio
0.85%
Aggregate Rating
Moderate Buy

ETF Overview

iShares Health Innovation Active ETF Expenses

TypeBMEDTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.85%0.57%0.57%0.51%0.53%
Other Expenses0.00%0.57%0.55%0.58%0.55%
Total Expense0.85%0.74%0.76%0.74%0.73%
Fee Waiver0.00%-0.74%-0.64%-0.70%-0.61%
Net Expense0.85%0.60%0.63%0.58%0.60%
Receive BMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Health Innovation Active ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BMED ETF News Headlines

A laboratory desk displays a tablet with health icons, a microscope, DNA model, and hourglass, with researchers working in the background.
3 Longevity ETFs to Buy and Hold (and Hold) (BMED)
The size of the longevity industry could roughly triple in the next decade, and these ETFs may help to provide access to a fast-growing space.
BNZI Breakout Watch: AI Growth Meets Turnaround Setup!
Banzai International (NASDAQ: BNZI) posted full-year 2025 revenue of $12.2 million, up 169% year-over-year, with Q4 growth of 116% and gross margins expanding to 81.9%. The company serves more than 150,000 customers and is building a unified AI platform spanning marketing automation, content creation, and sales acceleration. A planned acquisition of ConnectAndSell, expected to add roughly $15 million in annual revenue, could more than double BNZI's current scale. Rising earnings estimate revisions and a Zacks Rank upgrade to Buy signal growing institutional confidence in the company's improving fundamentals.tc pixel
iShares Health Innovation Active ETF
iShares A.I. Innovation and Tech Active ETF (BAI)
See More Headlines

BMED ETF - Frequently Asked Questions

iShares Health Innovation Active ETF's stock was trading at $30.32 at the start of the year. Since then, BMED stock has decreased by 6.1% and is now trading at $28.46.

Top institutional shareholders of iShares Health Innovation Active ETF include Sunbelt Securities Inc. (1.49%).

Shares of BMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Health Innovation Active ETF investors own include Horizon Technology Finance (HRZN), Gladstone Commercial (GOOD), Guardant Health (GH), GoodRx (GDRX), Farmland Partners (FPI), Cleveland-Cliffs (CLF) and

Fund Details

Issuer
iShares
Fund Name
iShares Health Innovation Active ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:BMED
Inception Date
9/29/2020
Fund Manager
Erin Xie, Jeff Lee, Xiang Liu
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
61

Fund Statistics

Assets Under Management
$10.24 million
Average Daily Volume
$0.00
Discount/Premium
0.01%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
BlackRock Fund Advisors
Custodian
State Street Bank and Trust Company
Distributor
BlackRock Investments, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
Optionable
Options Volume
2
Put Options
2
Call Options
2
Short Interest
3,700 shs

Miscellaneous

Beta
0.75
Creation Unit
40,000
Creation Fee
$900.00
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Top 10 BMED Holdings

BMED Sector Exposure

BMED Industry Exposure


This page (NYSEARCA:BMED) was last updated on 6/8/2026 by MarketBeat.com Staff.
From Our Partners